Diabetes Is a Risk Factor for the Prognosis of Patients with Bladder Cancer: A Meta-Analysis

Objective To systematically evaluate the impact of diabetes on the prognosis of bladder cancer patients after radical cystectomy (RC). Methods PubMed, Embase, and Cochrane Library databases were selected from inception to October 2021. The studies on the effects of diabetes on bladder cancer patients after RC were included for analysis. The inclusion and exclusion criteria were independently selected for literature screening, the quality of the included studies was evaluated, and data were extracted. Results A total of 5 cohort studies were included, with a total of 2 661 subjects, including 391 cases in the diabetic group, non-diabetes. Meta-analysis results show that diabetes increases the overall risk of death in patients after RC (HR = 1.36, 95% CI: 1.30 ∼ 1.43, P < 0.001) and the risk of tumor-specific death (HR = 1.59, 95% CI: 1.29 ∼ 1.95, P < 0.001). Sensitivity analysis shows that the stability of this study is well. Conclusion Diabetes was an independent risk factor in terms of overall and cancer-specific survival in patients who underwent RC.

[1]  S. Daneshmand,et al.  Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence. , 2020, European urology focus.

[2]  Funda Vakar Lopez.  Molecular subtyping bladder cancer: Is it ready for clinical practice? , 2020, Turkish journal of medical sciences.

[3]  C. Catalano,et al.  Overview of VI-RADS in Bladder Cancer. , 2020, AJR. American journal of roentgenology.

[4]  A. Porcaro,et al.  Bladder cancer genomics , 2020, Urologia.

[5]  L. Ballas,et al.  Trimodality therapy for bladder cancer: modern management and future directions , 2019, Current opinion in urology.

[6]  R. Romih,et al.  Lectins as possible tools for improved urinary bladder cancer management. , 2019, Glycobiology.

[7]  Jayoung Kim,et al.  Unmasking molecular profiles of bladder cancer , 2018, Investigative and clinical urology.

[8]  Bladder cancer: diagnosis and management of bladder cancer , 2017, BJU international.

[9]  L. Ibarz,et al.  Bladder cancer: Present and future. , 2017, Medicina clinica.

[10]  S. Poletajew,et al.  Factors affecting one-year survival after radical cystectomy: A prospective study , 2017, Central European journal of urology.

[11]  Kristen Farling.  Bladder cancer: Risk factors, diagnosis, and management. , 2017, The Nurse practitioner.

[12]  J. Oh,et al.  Association between diabetes mellitus and oncological outcomes in bladder cancer patients undergoing radical cystectomy , 2015, International journal of urology : official journal of the Japanese Urological Association.

[13]  M. Peller,et al.  Impact of stage and comorbidities on five-year survival after radical cystectomy in Poland: single centre experience , 2015, Central European journal of urology.

[14]  Xian-jin Wang,et al.  Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies , 2013, BMC Cancer.

[15]  J. Gore,et al.  Improving bladder cancer patient care: a pharmacoeconomic perspective , 2013, Expert review of anticancer therapy.

[16]  S. Larsson,et al.  Diabetes mellitus and risk of bladder cancer: a meta-analysis , 2006, Diabetologia.

[17]  M. Wirth,et al.  An easily applicable single condition-based mortality index for patients undergoing radical prostatectomy or radical cystectomy. , 2017, Urologic oncology.

[18]  Bladder cancer: Risk factors, diagnosis, and management. , 2017, The Nurse practitioner.

[19]  S. Skeldon,et al.  Bladder cancer: a portal into men's health. , 2015, Urologic oncology.

[20]  J. Bellmunt.  Bladder cancer. , 2015, Hematology/oncology clinics of North America.

[21]  M. Babjuk,et al.  Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma. , 2014, Urologic oncology.